Advances in molecular characterization of myeloid proliferations associated with Down syndrome

Abstract excerpt

Myeloid leukemia associated with Down syndrome (ML-DS) has a unique molecular landscape that differs from other subtypes of acute myeloid leukemia. ML-DS is often preceded by a myeloproliferative neoplastic condition called transient abnormal myelopoiesis (TAM) that disrupts megakaryocytic and erythroid differentiation. Over the last two decades, many genetic and epigenetic changes in TAM and ML-DS have been...

Topics

Join the communities discussing this publication.

• Acute Myeloid Leukemia Research
• Chronic Myeloid Leukemia Treatments
• Protein Degradation and Inhibitors